154 related articles for article (PubMed ID: 32985581)
1. Wnt signaling mediates oncogenic synergy between Akt and Dlx5 in T-cell lymphomagenesis by enhancing cholesterol synthesis.
Tan Y; Sementino E; Liu Z; Cai KQ; Testa JR
Sci Rep; 2020 Sep; 10(1):15837. PubMed ID: 32985581
[TBL] [Abstract][Full Text] [Related]
2. The homeoprotein Dlx5 drives murine T-cell lymphomagenesis by directly transactivating Notch and upregulating Akt signaling.
Tan Y; Sementino E; Xu J; Pei J; Liu Z; Ito TK; Cai KQ; Peri S; Klein-Szanto AJ; Wiest DL; Testa JR
Oncotarget; 2017 Feb; 8(9):14941-14956. PubMed ID: 28122332
[TBL] [Abstract][Full Text] [Related]
3. Co-targeting of Akt and Myc inhibits viability of lymphoma cells from Lck-Dlx5 mice.
Tan Y; Sementino E; Pei J; Kadariya Y; Ito TK; Testa JR
Cancer Biol Ther; 2015; 16(4):580-8. PubMed ID: 25793663
[TBL] [Abstract][Full Text] [Related]
4. A novel recurrent chromosomal inversion implicates the homeobox gene Dlx5 in T-cell lymphomas from Lck-Akt2 transgenic mice.
Tan Y; Timakhov RA; Rao M; Altomare DA; Xu J; Liu Z; Gao Q; Jhanwar SC; Di Cristofano A; Wiest DL; Knepper JE; Testa JR
Cancer Res; 2008 Mar; 68(5):1296-302. PubMed ID: 18316591
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of DLX5 promotes ovarian cancer cell proliferation by enhancing IRS-2-AKT signaling.
Tan Y; Cheung M; Pei J; Menges CW; Godwin AK; Testa JR
Cancer Res; 2010 Nov; 70(22):9197-206. PubMed ID: 21045156
[TBL] [Abstract][Full Text] [Related]
6. Recurrent chromosomal rearrangements implicate oncogenes contributing to T-cell lymphomagenesis in Lck-MyrAkt2 transgenic mice.
Timakhov RA; Tan Y; Rao M; Liu Z; Altomare DA; Pei J; Wiest DL; Favorova OO; Knepper JE; Testa JR
Genes Chromosomes Cancer; 2009 Sep; 48(9):786-94. PubMed ID: 19530243
[TBL] [Abstract][Full Text] [Related]
7. Targeting Wnt/β-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia.
Evangelisti C; Chiarini F; Cappellini A; Paganelli F; Fini M; Santi S; Martelli AM; Neri LM; Evangelisti C
J Cell Physiol; 2020 Jun; 235(6):5413-5428. PubMed ID: 31904116
[TBL] [Abstract][Full Text] [Related]
8. DLX5 (distal-less homeobox 5) promotes tumor cell proliferation by transcriptionally regulating MYC.
Xu J; Testa JR
J Biol Chem; 2009 Jul; 284(31):20593-601. PubMed ID: 19497851
[TBL] [Abstract][Full Text] [Related]
9. Miltefosine suppression of Pten null T-ALL leukemia via β-catenin degradation through inhibition of pT308-Akt and TGFβ1/Smad3.
Zhang Y; Lee S; Xu W
Biochem Biophys Res Commun; 2020 Apr; 524(4):1018-1024. PubMed ID: 32063363
[TBL] [Abstract][Full Text] [Related]
10.
Tan Y; Testa JR
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34203994
[TBL] [Abstract][Full Text] [Related]
11. Phospholipase D1 Inhibition Linked to Upregulation of ICAT Blocks Colorectal Cancer Growth Hyperactivated by Wnt/β-Catenin and PI3K/Akt Signaling.
Kang DW; Lee BH; Suh YA; Choi YS; Jang SJ; Kim YM; Choi KY; Min DS
Clin Cancer Res; 2017 Dec; 23(23):7340-7350. PubMed ID: 28939743
[No Abstract] [Full Text] [Related]
12. Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT/β-catenin and AKT/GSK3β proliferative signaling.
Chung J; Karkhanis V; Baiocchi RA; Sif S
J Biol Chem; 2019 May; 294(19):7692-7710. PubMed ID: 30885941
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor activates Wnt pathway by transcriptional activation of LEF1 to facilitate tumor invasion.
Huang FI; Chen YL; Chang CN; Yuan RH; Jeng YM
Carcinogenesis; 2012 Jun; 33(6):1142-8. PubMed ID: 22436613
[TBL] [Abstract][Full Text] [Related]
14. Induction of LEF1 by MYC activates the WNT pathway and maintains cell proliferation.
Hao YH; Lafita-Navarro MC; Zacharias L; Borenstein-Auerbach N; Kim M; Barnes S; Kim J; Shay J; DeBerardinis RJ; Conacci-Sorrell M
Cell Commun Signal; 2019 Oct; 17(1):129. PubMed ID: 31623618
[TBL] [Abstract][Full Text] [Related]
15. Wnt/β-catenin signaling pathway upregulates c-Myc expression to promote cell proliferation of P19 teratocarcinoma cells.
Zhang S; Li Y; Wu Y; Shi K; Bing L; Hao J
Anat Rec (Hoboken); 2012 Dec; 295(12):2104-13. PubMed ID: 22976998
[TBL] [Abstract][Full Text] [Related]
16. ALDH1B1 Is Crucial for Colon Tumorigenesis by Modulating Wnt/β-Catenin, Notch and PI3K/Akt Signaling Pathways.
Singh S; Arcaroli J; Chen Y; Thompson DC; Messersmith W; Jimeno A; Vasiliou V
PLoS One; 2015; 10(5):e0121648. PubMed ID: 25950950
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
Tang Y; Berlind J; Mavila N
Cell Commun Signal; 2018 Mar; 16(1):9. PubMed ID: 29530069
[TBL] [Abstract][Full Text] [Related]
18. A loss-of-function genetic screening reveals synergistic targeting of AKT/mTOR and WTN/β-catenin pathways for treatment of AML with high PRL-3 phosphatase.
Zhou J; Toh SH; Chan ZL; Quah JY; Chooi JY; Tan TZ; Chong PSY; Zeng Q; Chng WJ
J Hematol Oncol; 2018 Mar; 11(1):36. PubMed ID: 29514683
[TBL] [Abstract][Full Text] [Related]
19. β-Catenin mediates cyclic strain-stimulated cardiomyogenesis in mouse embryonic stem cells through ROS-dependent and integrin-mediated PI3K/Akt pathways.
Heo JS; Lee JC
J Cell Biochem; 2011 Jul; 112(7):1880-9. PubMed ID: 21433060
[TBL] [Abstract][Full Text] [Related]
20. Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer.
Arqués O; Chicote I; Puig I; Tenbaum SP; Argilés G; Dienstmann R; Fernández N; Caratù G; Matito J; Silberschmidt D; Rodon J; Landolfi S; Prat A; Espín E; Charco R; Nuciforo P; Vivancos A; Shao W; Tabernero J; Palmer HG
Clin Cancer Res; 2016 Feb; 22(3):644-56. PubMed ID: 26224873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]